Skip to main content

. 1979 Dec;8(6):594–595. doi: 10.1111/j.1365-2125.1979.tb01051.x

alpha-adrenoceptor mediated inhibition of human fat cell adenylate cyclase.

H Kather, J Pries, V Schrader, B Simon

PMCID: PMC1429901 PMID: 229889

594

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Arner P., Engfeldt P., Ostman J. Relationship between lipolysis, cyclic AMP, and fat-cell size in human adipose tissue during fasting and in diabetes mellitus. Metabolism. 1979 Mar;28(3):198–209. doi: 10.1016/0026-0495(79)90065-9. [DOI] [PubMed] [Google Scholar]
Kather H., Geiger M. Adrenaline-sensitive adenylate cyclase of human fat cell ghosts: properties and hormone-sensitivity. Eur J Clin Invest. 1977 Oct;7(5):363–371. doi: 10.1111/j.1365-2362.1977.tb01621.x. [DOI] [PubMed] [Google Scholar]
Kather H., Simon B. Catecholamine-sensitive adenylate cyclase of human fat cell ghosts: a comparative study using different beta-adrenergic agents. Metabolism. 1977 Nov;26(11):1179–1184. doi: 10.1016/0026-0495(77)90109-3. [DOI] [PubMed] [Google Scholar]
Kunos G. Adrenoceptors. Annu Rev Pharmacol Toxicol. 1978;18:291–311. doi: 10.1146/annurev.pa.18.040178.001451. [DOI] [PubMed] [Google Scholar]
Rosenqvist U. Inhibition of noradrenaline-induced lipolysis in hypothyroid subjects by increased -adrenergic responsiveness. An effect mediated through the reduction of cyclic AMP levels in adipose tissue. Acta Med Scand. 1972 Nov;192(5):353–359. doi: 10.1111/j.0954-6820.1972.tb04830.x. [DOI] [PubMed] [Google Scholar]
Salomon Y., Londos C., Rodbell M. A highly sensitive adenylate cyclase assay. Anal Biochem. 1974 Apr;58(2):541–548. doi: 10.1016/0003-2697(74)90222-x. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES